AUPH Stock Price
Aurinia Pharmaceuticals Inc.
AUPH stock price is $16.61 (+1.53% on the day), giving Aurinia Pharmaceuticals Inc. a market cap of $2.21B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
AUPH Stock Overview
- Price
- $16.61
- Previous close
- $16.36
- Open
- $16.24
- Market cap
- $2.21B
- P/E ratio
- 7.7
- 52-week range
- $10.90 - $19.25
- 1-year price target
- $17.75
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 65
About Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, focuses on delivering therapies to treat autoimmune diseases with unmet medical needs in the United States. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AUPH | $16.61 | +1.5% | 1.22M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aurinia Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW